Skip to content

CONNEQT Pulse Validation Study

Validation of the CONNEQT Blood Pressure Monitoring System in a Pregnant Patient Population

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06002971
Enrollment
41
Registered
2023-08-21
Start date
2023-08-21
Completion date
2025-06-03
Last updated
2026-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational Hypertension, Pre-Eclampsia, Pregnancy Related

Brief summary

The purpose of this study is to validate the accuracy of the CONNEQT Pulse blood pressure monitoring system for the measurement of blood pressure as compared to a gold standard, auscultatory sphygmomanometer in a pregnant population.

Detailed description

Clinical staff will review patient's medical record to determine eligibility. Following informed consent, a brief medical history will be collected. Serial blood pressure measurements will be collected to compare an auscultatory sphygmomanometer to blood pressure measurements of the CONNEQT Pulse blood pressure monitoring system in a pregnant population according to ISO protocol 81060-2.

Interventions

DEVICEBlood pressure measurement

Serial blood pressure measurements to compare reference auscultatory sphygmomanometer to CONNEQT Pulse according to ISO 81060-2.

Sponsors

Mount Carmel Health System
Lead SponsorOTHER
AtCor Medical, Inc.
CollaboratorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

All Groups: 1. Able to provide informed consent 2. Pregnant patient, beyond the first trimester (greater than 12 weeks of gestation) 3. 18 years of age, or older Normotensive: 1\. Systolic blood pressure \<140 mmHg (18,66 kPa) and diastolic blood pressure \<90 mmHg (12 kPa) Hypertensive: 1. Without proteinuria \>300 mg in 24 h; and 2. With systolic blood pressure ≥140 mmHg (18,66 kPa) or diastolic blood pressure ≥ 90 mmHg (12 kPa) Pre-Eclampsia: 1. With proteinuria \>300 mg in 24 h; and 2. With systolic blood pressure ≥140 mmHg (18,66 kPa) or diastolic blood pressure ≥ 90 mmHg (12,00 kPa)

Design outcomes

Primary

MeasureTime frameDescription
Comparison of reference auscultatory blood pressure readings to CONNEQT Pulse blood pressure readings.Up to 60 minutesPaired means and standard deviations of both systolic and diastolic blood pressure readings will be analyzed according to section 5.2.4.1.2 of ISO 81060-2 protocol.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 6, 2026